RALEIGH, N.C., March 20, 2025 /PRNewswire/ -- Endpoint Clinical ("Endpoint"), a global leader in randomization and trial supply management ("RTSM") solutions and a portfolio company of Arsenal Capital ...
DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to ...
DURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has signed a definitive agreement to ...
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic ...
VentureBeat presents: AI Unleashed - An exclusive executive event for enterprise data leaders. Network and learn with industry peers. Learn More Endpoint Clinical, provider of integrated response ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-B96 trial, ...
The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...
Using a novel proprietary clustering model from Endpoint Health, the study tested 10 different models, with varying combinations of proposed clinical variables. 1 The goal was to determine the optimal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback